About Navid Khodaparast
Form D filings for Spark Biomedical in 2023 list Navid Khodaparast as chief science officer and director.
Navid Khodaparast first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Navid Khodaparast in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Navid Khodaparast works with at each company, as listed on that company's latest Form D.
Spark Biomedical Inc. · Form D, May 12, 2023
AC
Alejandro Covalin
Chief Technology Officer and Director
TC
Ted Costopoulos
Director
CD
Carl Deeley
Director
DP
Daniel Powell
Chief Executive Officer and Director